MetLife Investment Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $191K | Buy |
|
|||||
|
2025
Q1 | $120K | Sell |
|
|||||
|
2024
Q4 | $111K | Buy |
|
|||||
|
2024
Q3 | $143K | Hold |
|
|||||
|
2024
Q2 | $252K | Buy |
|
|||||
|
2024
Q1 | $111K | Sell |
|
|||||
|
2023
Q4 | $91.1K | Hold |
|
|||||
|
2023
Q3 | $55.2K | Hold |
|
|||||
|
2023
Q2 | $62.1K | Hold |
|
|||||
|
2023
Q1 | $80.9K | Hold |
|
|||||
|
2022
Q4 | $134K | Hold |
|
|||||
|
2022
Q3 | $226K | Hold |
|
|||||
|
2022
Q2 | $149K | Hold |
|
|||||
|
2022
Q1 | $306K | Buy |
|
|||||
|
2021
Q4 | $299K | Hold |
|
|||||
|
2021
Q3 | $350K | Hold |
|
|||||
|
2021
Q2 | $509K | Hold |
|
|||||
|
2021
Q1 | $531K | Sell |
|
|||||
|
2020
Q4 | $827K | Hold |
|
|||||
|
2020
Q3 | $579K | Hold |
|
|||||
|
2020
Q2 | $575K | Buy |
|
|||||
|
2020
Q1 | $429K | Hold |
|
|||||
|
2019
Q4 | $859K | Buy |
|
|||||
|
2019
Q3 | $626K | Hold |
|
|||||
|
2019
Q2 | $629K | Buy |
|
|||||
|
2019
Q1 | $718K | Hold |
|
|||||
|
2018
Q4 | $762K | Hold |
|
|||||
|
2018
Q3 | $929K | Hold |
|
|||||
|
2018
Q2 | $1.14M | Buy |
|
|||||
|
2018
Q1 | $689K | Buy |
|
|||||
|
2017
Q4 | $399K | Buy |
|